Drug Type Bispecific antibody |
Synonyms- |
Target |
Action inhibitors |
Mechanism Ang2 inhibitors(Angiopoietin-2 inhibitors), VEGF inhibitors(Vascular endothelial growth factor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Preclinical | China | 04 Jan 2022 | |
Muscular Dystrophy, Duchenne | Discovery | China | 28 Jun 2022 |